Search

Author/Creator Dvory-Sobol, Hadas

1. 1585. Efficacy and safety of long-acting subcutaneous lenacapavir in heavily treatment-experienced people with multi-drug resistant HIV: Week 52 results. (15th December 2022)

Authors:
Ogbuagu, Onyema; Segal-Maurer, Sorana; Ratanasuwan, Winai; Trottier, Benoit; Brunetta, Jason; Shirasaka, Takuma; Koenig, Ellen L; Wang, Hui; Margot, Nicolas A; Dvory-Sobol, Hadas; Rhee, Martin S; Baeten, Jared; Molina, Jean-Michel
Journal:
Open forum infectious diseases
Issue:
Volume 9:(2022)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterization of HCV Resistance from a 3-Day Monotherapy Study of Voxilaprevir, a Novel Pangenotypic NS3/4A Protease Inhibitor. Issue 4 (May 2018)

Authors:
Lawitz, Eric; Yang, Jenny C; Stamm, Luisa M; Taylor, James G; Cheng, Guofeng; Brainard, Diana M; Miller, Michael D; Mo, Hongmei; Dvory-Sobol, Hadas
Journal:
Antiviral therapy
Issue:
Volume 23:Issue 4(2018)
Page Start:
325
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Deferred treatment with sofosbuvir–velpatasvir–voxilaprevir for patients with chronic hepatitis C virus who were previously treated with an NS5A inhibitor: an open-label substudy of POLARIS-1. (August 2018)

Authors:
Bourlière, Marc; Gordon, Stuart C; Schiff, Eugene R; Tran, Tram T; Ravendhran, Natarajan; Landis, Charles S; Hyland, Robert H; Stamm, Luisa M; Zhang, Jie; Dvory-Sobol, Hadas; Subramanian, G Mani; Brainard, Diana M; McHutchison, John G; Serfaty, Lawrence; Thompson, Alex J; Sepe, Thomas E; Curry, M...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 3:Number 8(2018)
Page Start:
559
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. IDDF2019-ABS-0136 Sofosbuvir/velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis. (June 2019)

Authors:
Borgia, Sergio; Dearden, Janet; Lurie, Yoav; Shafran, Stephen; Brown, Ashley; Hyland, Robert; Lu, Sophia; Markova, Svetlana; Dvory-Sobol, Hadas; Osinusi, Anu; Sze Man Yip, Christina; Yoshida, Eric; Calleja, Jose Luis; Gane, Edward
Journal:
Gut
Issue:
Volume 68(2019)Supplement 1
Page Start:
A138
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Issue 6 (June 2016)

Authors:
Manns, Michael; Samuel, Didier; Gane, Edward J; Mutimer, David; McCaughan, Geoff; Buti, Maria; Prieto, Martín; Calleja, José Luis; Peck-Radosavljevic, Markus; Müllhaupt, Beat; Agarwal, Kosh; Angus, Peter; Yoshida, Eric M; Colombo, Massimo; Rizzetto, Mario; Dvory-Sobol, Hadas; Denning, Jill; Arter...
Journal:
Lancet infectious diseases
Issue:
Volume 16:Issue 6(2016:Jun.)
Page Start:
685
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Ledipasvir/Sofosbuvir for 8, 12, or 24 Weeks in Hepatitis C Patients Undergoing Dialysis for End-Stage Renal Disease. (5th September 2021)

Authors:
Chuang, Wan-Long; Hu, Tsung-Hui; Buggisch, Peter; Moreno, Christophe; Su, Wei-Wen; Biancone, Luigi; Camargo, Marianne; Hyland, Robert; Lu, Sophia; Kirby, Brian J.; Dvory-Sobol, Hadas; Osinusi, Anu; Gaggar, Anuj; Peng, Cheng-Yuan; Liu, Chen-Hua; Sise, Meghan E.; Mangia, Alessandra
Journal:
American journal of gastroenterology
Issue:
Volume 116:Number 9(2021)
Page Start:
1924
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Ledipasvir/Sofosbuvir-Based Treatment of Patients with Chronic Genotype-1 HCV Infection and Cirrhosis: Results from Two Phase II Studies. Issue 8 (November 2016)

Authors:
Lawitz, Eric; Poordad, Fred; Hyland, Robert H; Wang, Jing; Liu, Lin; Dvory-Sobol, Hadas; Brainard, Diana M; McHutchison, John G; Gutierrez, Julio A
Journal:
Antiviral therapy
Issue:
Volume 21:Issue 8(2016)
Page Start:
679
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Ledipasvir–sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial. (May 2017)

Authors:
Rockstroh, Jürgen K; Bhagani, Sanjay; Hyland, Robert H; Yun, Chohee; Dvory-Sobol, Hadas; Zheng, Wei; Brainard, Diana M; Ingiliz, Patrick; Lutz, Thomas; Boesecke, Christoph; Nelson, Mark
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 2:Number 5(2017)
Page Start:
347
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗